Top Markets
#1 Brevis Brevis +37.75%
#2 Talus Network Talus Network +30.27%
#3 Tung Tung Tung Sahur Tung Tung Tung Sahur +30.12%
#4 Keep Network Keep Network +29.03%
#5 MemeCore MemeCore +24.60%
#6 Infinity Ground Infinity Ground +22.76%
#7 Allora Allora +20.35%
#8 Starpower Starpower +20.08%
#9 Synapse Synapse +18.93%
#10 屎壳郎 (Dung Beetle) 屎壳郎 (Dung Beetle) +18.73%
Coin of the day
Brevis Brevis
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
IntegraGen SA IntegraGen SA

IntegraGen SA

ALINT
Kedudukan dalam Saham #19673
IntegraGen SA provides human genome analysis services for academic researcher... IntegraGen SA provides human genome analysis services for academic researcher and life sciences companies in France. Its genomic services include transcriptomics, epigenomics, DNA sequencing, NGS testing for cancer research, and SNP genotyping. The company offers clinical research services, such as clinical grade sequencing and pharmacogenomics; basic and human genetic research; agrigenomic services, including crop and livestock genotyping and high-throughput sequencing for crops and livestock; and microbial genomics services comprising whole-genome microbial sequencing and microbial transcriptomics. It also provides MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and oncologists in transforming raw data obtained through high-throughput sequencing into a molecular report for translational and clinical research use; SIRIUS, a cloud-based software tool that enables researchers to analyze whole genome, whole exome, and gene panel sequencing data; Galileo, a cloud-based app for dynamic exporation of RNA-Seq expression data; and GeCo, a genomic consulting service that offers researchers with access to biostatistics and bioanalytics experts. IntegraGen SA was founded in 2000 and is headquartered in Évry, France. IntegraGen SA is a subsidiary of OncoDNA SA.
Harga Saham
$0.20342561
Modal Pasaran
$1.34M
Perubahan (1 hari)
-1.44%
Perubahan (1 tahun)
-65.74%
Negara
FR
Perdagangan IntegraGen SA (ALINT)

Kategori

Healthcare
Bilangan saham terbitan bagi IntegraGen SA (ALINT)
Bilangan saham terbitan setakat December 2025: 6.87M
Menurut laporan kewangan terkini dan harga saham IntegraGen SA, bilangan saham terbitan semasa ialah 6.87M. Pada akhir December 2023, syarikat mempunyai 6.61M saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk IntegraGen SA (ALINT) dari 2008 hingga 2026
Saham terbitan pada akhir setiap tahun
Tahun Saham Terbitan Ubah
2026 (TTM) 6.87M 1.95%
2024 6.74M 1.87%
2023 6.61M -0.22%
2022 6.63M 0.14%
2021 6.62M -0.41%
2020 6.65M 2.44%
2019 6.49M 0.35%
2018 6.46M -0.27%
2017 6.48M 29.14%
2016 5.02M -0.17%
2015 5.03M 1.70%
2014 4.94M 20.14%
2013 4.12M 0.00%
2012 4.12M 9.12%
2011 3.77M 0.00%
2010 3.77M 26.93%
2009 2.97M 0.00%
2008 2.97M 0.00%
Saham terbitan bagi syarikat atau pesaing yang serupa
Syarikat Saham Terbitan Perbezaan Negara
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 4.44B 64,584.67%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 254.10M 3,599.77%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 104.00M 1,414.27%
US
UCB SA UCB SA
UCB SA
UCB.BR
 190.00M 2,666.41%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 61.42M 794.28%
NL